Ingevity Corp
Business
Ingevity Corp provides products and technologies that purify, protect, and enhance the world by developing, manufacturing, and marketing specialty chemicals and materials. It offers activated carbon for automotive vapor control and purification; road technologies including asphalt emulsifiers, warm‑mix Evotherm, pavement preservation and markings; industrial specialties such as tall oil‑derived adhesives, agrochemical dispersants, lubricant additives and rubber resins; and caprolactone‑based polymers for coatings, adhesives, elastomers, bioplastics and medical devices. The company operates three reportable segments — Performance Materials, Performance Chemicals (road technologies and industrial specialties), and Advanced Polymer Technologies. It serves global markets across the Americas, Europe and Asia through its direct sales forces and a network of third‑party distributors to customers in automotive, construction, agriculture, industrial and medical end markets.
Summary from filing dated 2025-02-19
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net sales | 1,168 | 1,200 | 1,216 | 1,668 | 1,392 | |
| Cost of sales | 706 | 735 | 771 | 1,098 | 879 | |
| Gross profit | 462 | 465 | 445 | 570 | 513 | |
| Selling, general, and administrative expenses | 171 | 158 | 162 | 199 | 179 | |
| Research and technical expenses | 28 | 25 | 25 | 30 | 26 | |
| Restructuring and other (income) charges, net | 13 | 18 | 53 | 14 | — | |
| Goodwill impairment charge | 184 | 307 | 0 | 0 | — | |
| Long lived asset impairment charge | 109 | 0 | 0 | — | — | |
| Acquisition-related costs | 0 | 300,000 | 4 | 5 | 600,000 | |
| Other (income) expense, net | 25 | 8 | −16 | −2 | — | |
| Interest expense | 78 | 98 | 93 | 62 | — | |
| Interest income | −5 | −8 | −6 | −8 | −4 | |
| Income (loss) from continuing operations before income taxes | −142 | −141 | 130 | 270 | 163 | |
| Provision (benefit) for income taxes on continuing operations | 8 | −19 | 24 | 58 | 45 | |
| Net income (loss) from continuing operations | −150 | −121 | 106 | — | — | |
| Income (loss) from discontinued operations, net of income taxes | −17 | −309 | −111 | — | — | |
| Net income (loss) | −167 | −430 | −5 | 212 | 118 | |
| Basic earnings (loss) per share from continuing operations (usd per share) | −4.15 | −3.34 | 2.9 | — | — | |
| Basic earnings (loss) per share from continuing operations (usd per share) | −0.46 | −8.51 | −3.05 | — | — | |
| Basic earnings (loss) per share (usd per share) | −4.61 | −11.85 | −0.15 | 5.54 | 2.97 | |
| Diluted earnings (loss) per share from continuing operations (usd per share) | −4.15 | −3.34 | 2.88 | — | — | |
| Diluted earnings (loss) per share from discontinued operations (usd per share) | −0.46 | −8.51 | −3.03 | — | — | |
| Diluted earnings (loss) per share (usd per share) | −4.61 | −11.85 | −0.15 | 5.5 | 2.95 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 78 | 68 | 96 | 77 | 275 | |
| Accounts receivable, net of allowance of $1.5 - 2025 and $0.6 - 2024 | 127 | 132 | 182 | 225 | 162 | |
| Inventories, net | 186 | 196 | 309 | 335 | 241 | |
| Prepaid and other current assets | 47 | 51 | 72 | 47 | 47 | |
| Current assets of discontinued operations | 16 | 47 | — | — | — | |
| Current assets | 454 | 493 | 659 | 683 | 725 | |
| Property, plant, and equipment, net | 608 | 643 | 762 | 799 | 720 | |
| Operating lease assets, net | 30 | 45 | 67 | 57 | 52 | |
| Goodwill | 4 | 175 | 528 | 519 | 442 | |
| Other intangibles, net | 176 | 279 | 336 | 405 | 338 | |
| Deferred income taxes | 117 | 118 | 12 | 6 | 7 | |
| Restricted investment, net of allowance of $0.2 - 2025 and $0.2 - 2024 | 84 | 82 | 79 | 78 | 76 | |
| Strategic investments | 83 | 87 | 99 | 110 | 35 | |
| Other assets | 75 | 79 | 82 | 81 | 74 | |
| Noncurrent assets of discontinued operations | 20 | 22 | — | — | — | |
| Total Assets | 1,651 | 2,023 | 2,623 | 2,737 | 2,469 | |
| Accounts payable | 92 | 95 | 158 | 175 | 126 | |
| Accrued expenses | 148 | 58 | 72 | 54 | 52 | |
| Accrued payroll and employee benefits | 35 | 27 | 20 | 53 | 48 | |
| Current operating lease liabilities | 12 | 14 | 19 | 17 | 17 | |
| Notes payable and current maturities of long-term debt | 47 | 61 | 84 | 900,000 | 20 | |
| Income taxes payable | 5 | 6 | 9 | 4 | 6 | |
| Current liabilities of discontinued operations | 3 | 3 | — | — | — | |
| Current liabilities | 341 | 264 | 363 | 304 | 269 | |
| Long-term debt including finance lease obligations | 1,161 | 1,340 | 1,383 | 1,473 | 1,250 | |
| Noncurrent operating lease liabilities | 22 | 34 | 49 | 41 | 36 | |
| Deferred income taxes | 55 | 56 | 71 | 107 | 115 | |
| Other liabilities | 41 | 131 | 127 | 115 | 126 | |
| Noncurrent liabilities of discontinued operations | 700,000 | 3 | — | — | — | |
| Total Liabilities | 1,621 | 1,827 | 1,992 | 2,038 | 1,795 | |
| Commitments and contingencies (Note 17) | — | — | — | — | — | |
| Preferred stock (par value $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at 2025 and 2024) | 0 | 0 | 0 | 0 | 0 | |
| Common stock (par value $0.01 per share; 300,000,000 shares authorized; 43,891,710 and 43,630,211 issued and 35,485,876 and 36,350,425 outstanding at 2025 and 2024, respectively) | 400,000 | 400,000 | 400,000 | 400,000 | 400,000 | |
| Additional paid-in capital | 196 | 177 | 165 | 153 | 136 | |
| Retained earnings | 405 | 572 | 1,002 | 1,008 | 796 | |
| Accumulated other comprehensive income (loss) | 500,000 | −41 | −27 | −47 | 13 | |
| Treasury stock, common stock, at cost (8,405,834 shares - 2025 and 7,279,786 shares - 2024) | −572 | −513 | −510 | −416 | −272 | |
| Total Equity | 30 | 195 | 631 | 698 | 674 | |
| Total Liabilities and Equity | 1,651 | 2,023 | 2,623 | 2,737 | 2,469 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 106 | 108 | 123 | 109 | 110 | |
| Non cash operating lease costs | 15 | 19 | 19 | 16 | — | |
| Deferred income taxes | −5 | −121 | −45 | −5 | −5 | |
| Disposal/impairment of assets | 3 | 1 | 4 | 3 | 1 | |
| Restructuring and other (income) charges, net | 56 | 186 | 170 | 14 | — | |
| CTO resales | 0 | 53 | 22 | 0 | — | |
| LIFO liquidation | −7 | −6 | −29 | 10 | 4 | |
| Share-based compensation | 18 | 12 | 11 | 16 | 12 | |
| (Gain) loss on strategic investment | 26 | 11 | −19 | 0 | — | |
| Pension and other postretirement benefit costs | 1 | 2 | 2 | 1 | 2 | |
| Goodwill impairment charge | 184 | 349 | 0 | — | — | |
| Other non-cash items | 8 | 17 | 36 | 18 | 12 | |
| Accounts receivable, net | 12 | 38 | 43 | −42 | −14 | |
| Inventories, net | 40 | 73 | 26 | −64 | −56 | |
| Prepaid and other current assets | 1 | 8 | −29 | −800,000 | −6 | |
| Planned major maintenance outage | −7 | −7 | −13 | −9 | −9 | |
| Accounts payable | −3 | −63 | −15 | 43 | — | |
| Accrued expenses | −14 | −1 | −8 | 800,000 | — | |
| Accrued payroll and employee benefits | 7 | 8 | −34 | 5 | 23 | |
| Income taxes | −1 | −14 | 6 | 5 | −6 | |
| Operating leases | −20 | −22 | −23 | −19 | −21 | |
| Restructuring and other spending | −46 | −59 | −44 | −14 | −16 | |
| CTO resales | 6 | −46 | −11 | 0 | 0 | |
| Changes in all other operating assets and liabilities, net | 7 | 12 | 16 | 14 | 5 | |
| Net cash provided by (used in) operating activities | 331 | 129 | 205 | 313 | 293 | |
| Capital expenditures | −58 | −78 | −110 | −143 | −104 | |
| Proceeds from disposition of assets | 4 | 0 | — | — | — | |
| Sale (purchase) of strategic investments, net | −16 | −300,000 | 29 | — | — | |
| Restricted investment | 13 | 0 | 7 | — | — | |
| Other investing activities, net | 0 | −2 | −4 | −2 | 500,000 | |
| Net cash provided by (used in) investing activities | −58 | −80 | −77 | −552 | −139 | |
| Proceeds from revolving credit facility and other borrowings | 291 | 405 | 376 | 1,165 | — | |
| Payments on revolving credit facility and other borrowings | −484 | −471 | −383 | −337 | 0 | |
| Debt issuance costs | 0 | 0 | −400,000 | −3 | 0 | |
| Financing lease obligations, net | −1 | −1 | −700,000 | −900,000 | −700,000 | |
| Tax payments related to withholdings on vested equity awards | −4 | −3 | −5 | −2 | −2 | |
| Proceeds and withholdings from share-based compensation plans, net | 1 | 0 | 5 | 4 | 5 | |
| Repurchases of common stock under publicly announced plan | −56 | 0 | −92 | −145 | −109 | |
| Net cash provided by (used in) financing activities | −252 | −70 | −100 | 48 | −133 | |
| Increase (decrease) in cash, cash equivalents, and restricted cash | 22 | −21 | 28 | −190 | 22 | |
| Effect of exchange rate changes on cash | 5 | −4 | −300,000 | −6 | −2 | |
| Change in cash, cash equivalents, and restricted cash | 26 | −25 | 28 | −196 | 20 | |
| Cash paid for interest, net of capitalized interest | 70 | 85 | 83 | 55 | 48 | |
| Cash paid for income taxes, net of refunds | 11 | 27 | 30 | 55 | 54 | |
| Purchases of property, plant, and equipment in accounts payable | 2 | 2 | 3 | 5 | 9 | |
| Leased assets obtained in exchange for new finance lease liabilities | 0 | 0 | 200,000 | 0 | 0 | |
| Leased assets obtained in exchange for new operating lease liabilities | 2 | 6 | 29 | 24 | 21 |